Dana-Farber Cancer Institute – Harvard Medical School Metastatic breast cancer (MBC) – breast cancer that has spread to other organs – unfortunately remains incurable. In spite of the increasing number of treatments available that can benefit patients with MBC, the disease eventually develops resistance to each therapy. As such, there is a critical need to […]
Daniel L. Abravanel, MD, PhD Read More »
Memorial Sloan Kettering Cancer Center A growing problem facing cancer patients today is metastatic disease, especially metastases to the central nervous system (CNS). As things stand today, we have large knowledge gaps in understanding why some breast cancer becomes metastatic to the CNS and how we can effectively identify CNS disease earlier. CNS disease is
Massachusetts General Hospital – Harvard Medical School Circulating tumor cells (CTCs) are cells that are derived from a tumor, but are isolated from the blood of cancer patients. Only recently has technological advances permitted the isolation and characterization of these rare cells. CTCs offer a snapshot of the invasive cancer cells that give rise to
Douglas Micalizzi MD, PhD Read More »
Dana-Farber Cancer Institute – Harvard Medical School Currently one in eight women in the US are predicted to develop breast cancer in their lifetime, but what is unknown is how many of these cancers can be prevented through advances in precision medicine. At this time, prevention strategies focus on radiographic screening for patients above a
Jennifer Rosenbluth, MD, PhD Read More »
